Van Heeke; Gino
Patent Applications and Registrations
Patent applications and USPTO patent grants for Van Heeke; Gino.The latest application filed is for "rnai inhibition of alpha-enac expression".
- Van Heeke; Gino - Upper Beeding GB
- Van Heeke; Gino - Eine BE
- Van Heeke; Gino - Horsham N/A GB
- Van Heeke; Gino - Bodenmattstrasse BE
- van Heeke; Gino - Gainesville FL
- Van Heeke; Gino - Lincoln NE
| Patent | Date |
|---|---|
| RNAi Inhibition of Alpha-ENaC Expression App 20220235361 - Van Heeke; Gino ; et al. | 2022-07-28 |
| RNAi Inhibition of Alpha-ENaC Expression App 20220112505 - Van Heeke; Gino ; et al. | 2022-04-14 |
| RNAi inhibition of alpha-ENaC expression Grant 11,208,662 - Van Heeke , et al. December 28, 2 | 2021-12-28 |
| RNAi Inhibition of Alpha-ENaC Expression App 20200157550 - Van Heeke; Gino ; et al. | 2020-05-21 |
| TNF binders Grant 10,544,211 - Buyse , et al. Ja | 2020-01-28 |
| RNAi inhibition of alpha-ENaC expression Grant 10,544,418 - Van Heeke , et al. Ja | 2020-01-28 |
| RNAi Inhibition of Alpha-ENaC Expression App 20180148726 - Van Heeke; Gino ; et al. | 2018-05-31 |
| RNAi inhibition of alpha-ENaC expression Grant 9,914,927 - Van Heeke , et al. March 13, 2 | 2018-03-13 |
| Tnf Binders App 20170267752 - Buyse; Marie-Ange ; et al. | 2017-09-21 |
| TNF binders Grant 9,745,372 - Buyse , et al. August 29, 2 | 2017-08-29 |
| Improved Tnf Binders App 20170190769 - Buyse; MARIE-ANGE ; et al. | 2017-07-06 |
| RNAi Inhibition of Alpha-ENaC Expression App 20160376599 - Van Heeke; Gino ; et al. | 2016-12-29 |
| RNAi inhibition of alpha-ENaC expression Grant 9,476,052 - Van Heeke , et al. October 25, 2 | 2016-10-25 |
| RNAi Inhibition of A1pha-ENaC Expression App 20150284726 - VAN HEEKE; Gino ; et al. | 2015-10-08 |
| RNAi inhibition of alpha-ENaC expression Grant 9,074,212 - Van Heeke , et al. July 7, 2 | 2015-07-07 |
| Chemokine receptor binding polypeptides Grant 8,591,896 - Bradley , et al. November 26, 2 | 2013-11-26 |
| Chemokine Receptor Binding Polypeptides App 20120183549 - BRADLEY; Michelle ; et al. | 2012-07-19 |
| RNAi inhibition of alpha-ENaC expression Grant 8,168,606 - Van Heeke , et al. May 1, 2 | 2012-05-01 |
| RNAi inhibition of alpha-ENaC expression Grant 8,119,612 - Van Heeke , et al. February 21, 2 | 2012-02-21 |
| RNAi inhibition of alpha-ENaC expression Grant 7,943,592 - Van Heeke , et al. May 17, 2 | 2011-05-17 |
| RNAi inhibition of alpha-ENaC expression Grant 7,939,508 - Van Heeke , et al. May 10, 2 | 2011-05-10 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100216972 - VAN HEEKE; Gino ; et al. | 2010-08-26 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100216971 - VAN HEEKE; Gino ; et al. | 2010-08-26 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100210514 - VAN HEEKE; Gino ; et al. | 2010-08-19 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100210513 - VAN HEEKE; Gino ; et al. | 2010-08-19 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100190714 - VAN HEEKE; Gino ; et al. | 2010-07-29 |
| RNAi inhibition of alpha-ENaC expression Grant 7,718,632 - Van Heeke , et al. May 18, 2 | 2010-05-18 |
| RNAi Inhibition of Alpha-ENaC Expression App 20090156529 - VAN HEEKE; Gino ; et al. | 2009-06-18 |
| C5A receptor antagonists having substantially no agonist activity Grant 5,807,824 - van Oostrum , et al. September 15, 1 | 1998-09-15 |
| Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment Grant 5,595,887 - Coolidge , et al. January 21, 1 | 1997-01-21 |
| Sequential oligonucleotide syntheses using immunoaffinity techniques Grant 5,464,759 - Coolidge , et al. November 7, 1 | 1995-11-07 |
| Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques Grant 5,221,736 - Coolidge , et al. June 22, 1 | 1993-06-22 |
| Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques Grant 5,049,656 - Lewis , et al. September 17, 1 | 1991-09-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 